Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Major drug resistance mutations to HIV-1 protease inhibitors (PI) among patients exposed to PI class failing antiretroviral therapy in São Paulo State, Brazil

Fig 1

Major drug resistance mutations in patients failing therapy and exposed to at least one PI.

Proportion of sequences with protease (PT) and reverse transcriptase (RT) mutations, presented by each resistance-associated codon, according to antiretroviral (ARV) class. (A) Major mutations to nucleoside RT inhibitors (NRTIs). (B) Major mutations to non-nucleoside RT inhibitors (NNRTI). (C) Major mutations to protease inhibitors (PI). Data according to the Stanford HIV Resistance Database.

Fig 1